NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054142

Registered date:13/04/2024

Clinical Study on Dotinurad for Hyperuricemia

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedHyperuricemic patients with uric acid levels of 7.0 mg/dL or higher
Date of first enrollment2024/03/16
Target sample size40
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcomeuric acid
Secondary Outcome1) BUN, Cr, eGFR 2) Cystatin C 3) Oxidized LDL, high sensitivity CRP 4) Albuminuria 5) Side effects

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients who were deemed not appropriate to participate in this study by doctor

Related Information

Contact

public contact
Name Mitsue Akiyama
Address 3-28-3 Ikebukuro, Toshima-ku, Tokyo, Japan Japan 1710014
Telephone 03-3986-5501
E-mail skn-np@sekino-hospital.com
Affiliation Sekino Laboratory Department of Research
scientific contact
Name Akira Sezai
Address 30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan Japan
Telephone 03-3972-8111
E-mail asezai.med@gmail.com
Affiliation Nihon University School of Medicine Department of Cardiovascular Surgery